Preprints.org·May 19A Modified Simplified Frailty Score Predicts Survival, Toxicity, and Treatment Selection in Elderly Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Cohort StudyPreprint: cohort study of 117 peopleBiomarkersPaper
Blood Advances·Feb 4Incidence, timing, and prognosis of heart failure after treatment for large B-cell lymphoma in Sweden during 2007-2022Cohort study of 8,453 peopleHeart failurePaper
Cancers·Jan 8The Role of the Lawton Instrumental Activities of Daily Living (IADL) Scale in Predicting Adverse Events and Outcomes of R-CHOP Treatment in Elderly Patients with Diffuse Large B-Cell Lymphomas (DLBCLs) or Mantle Cell Lymphomas (MCLs): A Prospective Single-Center StudyCohort study of 62 peopleBiomarkersPaper
Clinical Lymphoma, Myeloma & Leukemia·Jul 25Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original ArticleStudy of 31 peopleFrailtyPaper
Annals of Hematology·Apr 28Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphomaCohort study of 337 peopleFrailty scorePaper
Blood Advances·Sep 21A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCLCohort study of 784 peopleBiomarkersPaper
American Journal of Hematology·Apr 16A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO groupCohort study of 252 peopleBiomarkersPaper